ALNYLAM PHARMACEUTICALS, INC. Annual Operating Margin in % from 2019 to 2022

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Alnylam Pharmaceuticals, Inc. quarterly/annual Operating Margin history and growth rate from 2019 to 2022.
  • Alnylam Pharmaceuticals, Inc. Operating Margin for the quarter ending December 31, 2022 was -75.7 %, a 9.84% increase year-over-year.
  • Alnylam Pharmaceuticals, Inc. annual Operating Margin for 2022 was -75.7 %, a 9.84% increase from 2021.
  • Alnylam Pharmaceuticals, Inc. annual Operating Margin for 2021 was -83.9 %, a 50.1% increase from 2020.
  • Alnylam Pharmaceuticals, Inc. annual Operating Margin for 2020 was -168 %, a 60.7% increase from 2019.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 -75.7 +8.26 +9.84% Jan 1, 2022 Dec 31, 2022
2021 -83.9 +84.2 +50.1% Jan 1, 2021 Dec 31, 2021
2020 -168 +259 +60.7% Jan 1, 2020 Dec 31, 2020
2019 -428 Jan 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.